Low baseline salivary 3-methoxy-4-hydroxyphenylglycol (MHPG) in drug-naïve patients with short-illness-duration first episode major depressive disorder-Reference-Cited by-同舟云学术

Low baseline salivary 3-methoxy-4-hydroxyphenylglycol (MHPG) in drug-naïve patients with short-illness-duration first episode major depressive disorder

Published:2014-06 Issue: Volume:161 Page:4-7
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

Cubała Wiesław Jerzy,Landowski Jerzy,Wielgomas Bartosz,Czarnowski Wojciech

Funder

Servier

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference20 articles.

1. Total plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) in Alzheimer patients: comparison with depressives and normal controls;Azorin;Int. J. Geriatric Psychiatry,1990

2. The role of noradrenaline and selective noradrenaline reuptake inhibition in depression;Brunello;Eur. Neuropsychopharmacol.,2002

3. C-reactive protein and cortisol in drug-naïve patients with short-illness-duration first episode major depressive disorder: possible role of cortisol immunomodulatory action at early stage of the disease;Cubała;J. Affect. Disorders,2014

4. Saliva levels of 3-methoxy-4-hydroxyphenylglycol and clinical efficacy of mirtazapine or selective serotonin reuptake inhibitors in patients with major depression;Egami;Hum. Psychopharmacol.,2013

5. Lifetime burden of mood swings and activation of brain norepinephrine turnover in patients with treatment-refractory depressive illness;Ehnvall;J. Affect. Disorders,2003

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stress in the age of the COVID-19 pandemic from a subjective perspective of a psychiatrist;Psychiatria i Psychologia Kliniczna;2020-07-27

2. Salivary 3-methoxy-4-hydroxyphenylglycol increases after awakening in healthy young adults;Psychophysiology;2014-09-14